Cite
HARVARD Citation
Isenberg, D. et al. (n.d.). OP0184 Efficacy and Safety of Tabalumab in Patients with Systemic Lupus Erythematosus (SLE): Results from 2 Phase 3, 52-Week, Multicenter, Randomized, Placebo-Controlled Trials. Annals of the rheumatic diseases. p. 141. [Online].